Literature DB >> 32914957

X-ray-Induced Cherenkov Optical Triggering of Caged Doxorubicin Released to the Nucleus for Chemoradiation Activation.

Cuiping Yao1,2, Jiong Li2, Xu Cao1,3, Jason R Gunn1, Ming Wu4, Shudong Jiang1,5, Brian W Pogue1,2,5.   

Abstract

Concurrent chemoradiotherapy is used for advanced cancers, but the chemotherapy is dose limited by normal tissue toxicity. Localized X-ray activation of chemotherapy could overcome this, as studied here, with release from self-assembled nanomicelles (NMs) created from copolymers loaded with doxorubicin (DOX) having a photocleavable o-nitrobenzyl ester (o-Ne) group. The micelles demonstrated release of DOX from X-ray-induced Cherenkov light and conversion from a caged hydrophobic form to hydrophilic DOX, which achieves nuclear localization. Folate on the exterior of the NMs directed them for effective intracellular uptake prior to irradiation. Irradiation with 8 Gy released the DOX, which then entered the cell nucleus, providing near-complete in vivo tumor eradication and negligible off-target organ damage. Micelles were assembled from molecular component materials that are commonly in human use. This study realizes triple targeting in chemoradiation with potential for cell-receptor-mediated uptake, localized radiotherapy activation, and nuclear relocalization, all leading to limited off-target toxicity.

Entities:  

Keywords:  Cherenkov; X-ray; folic acid; irradiation; nanoparticles; nanotechnology; theranostic

Mesh:

Substances:

Year:  2020        PMID: 32914957     DOI: 10.1021/acsami.0c05189

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  4 in total

1.  Review of in vivo optical molecular imaging and sensing from x-ray excitation.

Authors:  Brian W Pogue; Rongxiao Zhang; Xu Cao; Jeremy Mengyu Jia; Arthur Petusseau; Petr Bruza; Sergei A Vinogradov
Journal:  J Biomed Opt       Date:  2021-01       Impact factor: 3.170

2.  Light-Sensitive Phenacyl Crosslinked Dextran Hydrogels for Controlled Delivery.

Authors:  Tobias G Brevé; Mike Filius; Sven Weerdenburg; Stefan J van der Griend; Tim P Groeneveld; Antonia G Denkova; Rienk Eelkema
Journal:  Chemistry       Date:  2022-01-27       Impact factor: 5.020

Review 3.  Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment.

Authors:  Simran Nasra; Dhiraj Bhatia; Ashutosh Kumar
Journal:  Nanoscale Adv       Date:  2022-07-26

4.  Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression.

Authors:  Jiayi Chen; Chenhong Qian; Peng Ren; Han Yu; Xiangjia Kong; Chenglong Huang; Huanhuan Luo; Gang Chen
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.